Atossa Therapeutics, Inc. Common Stock (ATOS) is a publicly traded Healthcare sector company. As of September 22, 2026, ATOS trades at $2.33 with a market cap of $22.15M and a P/E ratio of -0.57. ATOS moved +1.58% today. Year to date, ATOS is -74.58%; over the trailing twelve months it is -82.33%. Its 52-week range spans $1.70 to $19.35. Analyst consensus is buy with an average price target of $11.00. Rallies surfaces ATOS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest ATOS news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $2.33 |
| Market Cap | $22.15M |
| P/E Ratio | -0.57 |
| EPS | $-4.04 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.35 |
| 52-Week Low | $1.70 |
| Volume | 60.78K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-34.77M |
| Gross Margin | 0.00% |
2 analysts cover ATOS: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $11.00.